v3.26.1
Consolidated Statement Of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (10,590,822) $ (4,985,044)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 269,607 335,137
Stock-based compensation 447,545 221,464
Issuance of common stock shares for services 2,631,799 0
Amortization of debt discounts 1,207,730 321,941
Warrant modifications of the terminated inducement offering charged to operations 514,313 0
Reserve for expected credit losses 17,864 (10,298)
Impairment of intangible assets and investments 449,685 0
Change in fair value of derivative liabilities (187,753) 0
Change in fair value of SAFE 21,062 0
Inventory obsolescence 246,385 8,885
Loss on sale of securities at fair value 0 280,143
Changes in operating assets and liabilities    
Accounts receivable (1,744,094) (825,207)
Inventory, net (581,023) 2,907,233
Prepaid expenses and other current assets (297,200) 11,733
Accounts payable 1,359,803 (654,654)
Accrued expenses 173,882 (728,991)
Interest receivable 0 (25,887)
Interest payable 41,768 1,799,123
Customer deposits (3,162) 0
Contract liabilities (108,942) (2,122)
Net cash used in operating activities (6,131,553) (1,346,544)
Cash flows from investing activities    
Advances to related parties (3,717) (87,686)
Sale of investment 0 500,000
Proceeds from notes receivable 0 346,663
Purchase of related-party investment (1,786,593) 0
Purchases of property and equipment, net of disposals 0 11,610
Purchases / disposals of intangible assets, net 0 (17,470)
Net cash (used in) provided by investing activities (1,790,310) 753,117
Cash flows from financing activities    
Proceeds from (repayments of) secured credit facility, net 511,488 (125,854)
Repayments of loans payable, net (197,854) (137,959)
Proceeds from (repayments of) promissory notes, net 0 945,000
Proceeds from (repayments of) convertible notes, net 1,351,675 0
Proceeds from issuance of Series C Convertible Preferred Stock 7,000,000 0
Proceeds from issuance of Common Stock 0 470,759
Offering costs (452,512) (396,755)
Proceeds from exercise of stock options 4,184 375
Proceeds from exercise of warrants 850,437 51,406
Obligation under repurchase agreement (400,000) 0
Net cash provided by financing activities 8,667,418 806,972
Net change in cash and cash equivalents 745,555 213,545
Cash and cash equivalents, beginning of the period 824,962 693,946
Cash and cash equivalents, end of the period 1,570,517 907,491
Supplemental Disclosure of Cash Flow Information    
Cash paid for income taxes 9,373 13,833
Cash paid for interest 340,352 516,353
Noncash Investing and Financing Activities    
Transfer of investment for relief of debt 0 1,000,000
Warrants issued with promissory notes 0 615,427
Exchange of shareholder promissory note for convertible note 1,000,000 0
Conversion of Convertible Notes and accrued interest into Common Stock 3,791,850 0
Common Stock issued as Series C commitment fee shares 450,000 0
Incremental fair value of Warrant modifications capitalized to deferred offering costs 431,680 0
Shares issued in extinguishment of accrued interest 276,475 0
Reclassification of securities pledged as collateral to investments at fair value upon De Soi collateral release 3,347,564 0
Issuance of SAFE for reduction of promissory note principal 0 500,000
Derivative recognized with Series C financing 849,236 0
Warrants issued with Series C Preferred Stock $ 4,824,382 $ 0